A Phase 2 interventional study of Ropivacaine - Tramadol and Ropivacaine in Shoulder Fracture, Shoulder Dislocation and Rotator Cuff Injury, sponsored by Asklepieion Voulas General Hospital. Completed at 1 site in Greece. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2016-01-05.
Sponsored by Asklepieion Voulas General Hospital · Phase 2, Interventional, and Treatment
The purpose of our study is to evaluate the effect of tramadol as an adjunct to ropivacaine local anesthetic solution in interscalene brachial plexus block for shoulder surgery.
103 studies on the registry are indexed under Shoulder Dislocation; 23 are open to participants now.
This study's enrollment of 80 is above the median of 60 across 70 interventional studies indexed under Shoulder Dislocation.
Browse Shoulder Dislocation studies →Asklepieion Voulas General Hospital is the lead sponsor of 13 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Ropivacaine - Tramadol
Drug: Ropivacaine
Interscalene block using ropivacaine plus tramadol
Interscalene block using ropivacaine
Postoperative analgesia
Time frame: 24 hours postoperatively
Persistent postoperative pain
Time frame: 1 month postoperatively, 3 months postoperatively
Evidence of motor blockade resolution, confirmed by elbow - wrist - fingers active movement
Time frame: 24 hours postoperatively
Evidence of sensory blockade resolution, confirmed by pin-prick test
Time frame: 24 hours postoperatively
This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Asklepieion Voulas General Hospital